Marcos Lopez-Hoyos
Overview
Explore the profile of Marcos Lopez-Hoyos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
203
Citations
2166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Camacho Saez B, Martinez-Taboada V, Merino A, Comins-Boo A, Gonzalez-Mesones B, Del Barrio-Longarela S, et al.
Biomedicines
. 2024 Jun;
12(6).
PMID: 38927381
Inherited thrombophilia (IT) has been implicated as a potential causal factor of adverse pregnancy outcomes (APOs), including recurrent miscarriage with and without the presence of antiphospholipid syndrome (APS). The aim...
12.
Comins-Boo A, Irure-Ventura J, Valentin M, Belmar-Vega L, Lopez Del Moral Cuesta C, Valero San Cecilio R, et al.
Hum Immunol
. 2024 Apr;
85(3):110806.
PMID: 38664156
Donor exchange programs were designed to allocate organs for highly sensitized (HS) patients. The allocation algorithm differs slightly among countries and includes different strategies to improve access to transplants in...
13.
Iglesias-Escudero M, San Segundo D, Lopez-Hoyos M
Methods Cell Biol
. 2024 Mar;
184:69-84.
PMID: 38555159
Among myeloid regulatory cells (MRCs), some particular subsets termed myeloid-derived suppressor cells (MDSCs) have been described. They are suppressor myeloid cells characterized by their ability to regulate innate and adaptive...
14.
Martinez-Dubarbie F, Lopez-Garcia S, Lage C, Di Molfetta G, Fernandez-Matarrubia M, Pozueta-Cantudo A, et al.
J Alzheimers Dis
. 2024 Mar;
98(3):1029-1042.
PMID: 38489191
Background: Plasma biomarkers of Alzheimer's disease (AD) constitute a non-invasive tool for diagnosing and classifying subjects. They change even in preclinical stages, but it is necessary to understand their properties...
15.
Sanchez-Soblechero A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, Irure J, Lopez-Hoyos M, et al.
J Alzheimers Dis
. 2024 Mar;
98(3):957-967.
PMID: 38489172
Background: The optimal cut-off for Alzheimer's disease (AD) CSF biomarkers remains controversial. Objective: To analyze the performance of cut-off points standardized by three methods: one that optimized the agreement between...
16.
Martinez-Dubarbie F, Guerra-Ruiz A, Lopez-Garcia S, Irure-Ventura J, Lage C, Fernandez-Matarrubia M, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338759
Plasma biomarkers for Alzheimer's disease (AD) are a promising tool that may help in early diagnosis. However, their levels may be influenced by physiological parameters and comorbidities that should be...
17.
Rojo R, Calvo Alen J, Prada A, Valor S, Roy G, Lopez-Hoyos M, et al.
Autoimmun Rev
. 2024 Jan;
23(2):103517.
PMID: 38237216
No abstract available.
18.
Alonso-Pena M, Dierssen T, Marin M, Alonso-Molero J, Gomez-Acebo I, Santiuste I, et al.
BMC Public Health
. 2023 Dec;
23(1):2429.
PMID: 38053113
Cantabria Cohort stems from a research and action initiative lead by researchers from Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital and University of Cantabria, supported by the regional...
19.
Ezcurra I, Puente A, Cuadrado A, Tamayo I, Iruzubieta P, Arias-Loste M, et al.
United European Gastroenterol J
. 2023 Nov;
11(10):1010-1020.
PMID: 38015591
Background: Preliminary evidence suggests that inherited hypercoagulable disorders can lead to an increased risk of significant liver fibrosis. Objective: We aimed to investigate the prevalence of significant fibrosis in patients...
20.
Rojo R, Calvo Alen J, Prada A, Valor S, Roy G, Lopez-Hoyos M, et al.
Autoimmun Rev
. 2023 Nov;
22(12):103479.
PMID: 37967782
Anti-dsDNA autoantibodies are listed as one of the classification criteria for systemic lupus erythematosus (SLE) and are relatively effective indicators for monitoring disease activity and treatment response. Therefore, clinicians rely...